한글목차

세포 수확기 세계 시장은 2024년에 32억 1,000만 달러로 평가되었습니다. 2030년에는 46억 3,000만 달러에 이르고, CAGR 6.48%를 보일 것으로 예측됩니다.

세포 수확기는 임상, 연구, 치료 현장에서 사용하기 위해 생물학적 물질로부터 세포를 분리 및 수집하는 데 사용되는 특수 시스템입니다. 이러한 기술은 재생의료, 암 치료, 개인맞춤형 진단 등 다양한 용도에 필수적입니다. 전 세계적으로 세포 기반 치료와 생물 의학 연구의 발전이 가속화됨에 따라 선진국과 개발도상국 모두에서 이러한 도구의 채택이 증가하고 있습니다. 이 시장은 정밀의료와 줄기세포 치료에 대한 수요 증가에 힘입어 성장하고 있지만, 높은 장비 비용, 복잡한 규제, 대규모 세포 취급에 대한 기술적 요구와 관련된 과제를 해결해야 하는 과제를 안고 있습니다.

시장 성장 촉진요인

헬스케어 산업의 성장

주요 시장 이슈

장비 및 치료의 높은 비용

주요 시장 동향

재생의료와 맞춤형 의료의 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 세포 수확기 시장에 미치는 영향

제5장 세계의의 세포 수확기 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(변위 컬렉터, 치료 컬렉터)
  • 용도별(세포 증식 어세이, 혼합 림프구 배양(MLC) 어세이, 수용체 결합 어세이, 단일 가닥 템플릿 DNA 채취, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 세포 수확기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 세포 수확기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 세포 수확기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 세포 수확기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 세포 수확기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 세계의 세포 수확기 시장 : SWOT 분석

제15장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• Human Med AG
• ADS Biotec Inc.
• PerkinElmer Inc.
• Cytiva
• TERUMO BCT, INC.
• Esco Micro Pte. Ltd.
• Gasser Apparatebau und Laborzubehor
• Sartorius AG
• Cox Scientific Ltd.
• Pall Corporation

제17장 전략적 제안

제18장 회사 소개 및 면책조항

영문목차

The Global Cell Harvester Market was valued at USD 3.21 Billion in 2024 and is projected to reach USD 4.63 Billion by 2030, growing at a CAGR of 6.48%. Cell harvesters are specialized systems used to isolate and collect cells from biological materials for use in clinical, research, and therapeutic settings. These technologies are integral to a wide range of applications, including regenerative medicine, cancer treatment, and personalized diagnostics. As advancements in cell-based therapies and biomedical research accelerate globally, both developed and developing regions are witnessing increased adoption of these tools. The market is being propelled by growing demand for precision medicine and stem cell therapies, even as it contends with challenges related to high equipment costs, regulatory complexity, and the technical demands of large-scale cell handling.

Key Market Drivers

Growth in Healthcare Industry

The global expansion of the healthcare industry is a key factor driving growth in the cell harvester market. With annual revenues surpassing USD 4 trillion, the healthcare sector is undergoing significant evolution, particularly in pharmaceuticals and biotechnology, which together contribute approximately USD 850 billion. Medical technology and diagnostics follow closely, accounting for more than USD 400 billion. This expansive growth is translating into increased investments in advanced medical equipment-including cell harvesting systems-particularly in areas such as precision medicine and regenerative therapies. As healthcare systems in both developed and emerging economies adopt innovative treatment approaches, the need for efficient and reliable cell harvesting tools continues to rise across clinical and research domains.

Key Market Challenges

High Cost of Devices and Procedures

A significant obstacle to broader market adoption is the high cost associated with cell harvesting devices and their related procedures. Devices intended for clinical-grade cell extraction often incorporate advanced features such as full automation, closed-loop systems, and sterile processing capabilities, all of which contribute to higher upfront and operational costs. These financial demands can be prohibitive for smaller healthcare institutions, research labs, and mid-sized biopharmaceutical firms, especially in cost-sensitive regions. Additional expenditures related to equipment setup, maintenance, operator training, and consumables further increase the economic burden. In many developing markets, constrained healthcare budgets limit the accessibility and deployment of advanced biotechnology solutions, posing a barrier to growth.

Key Market Trends

Advancements in Regenerative & Personalized Medicine

The accelerating progress in regenerative and personalized medicine is a pivotal trend shaping the global cell harvester market. These fields rely on the extraction and preparation of patient-specific cells for therapies aimed at tissue repair, organ regeneration, and immune modulation. Stem cell-based interventions, including the use of embryonic, adult, and induced pluripotent stem cells, require precise harvesting techniques to ensure cell viability and therapeutic efficacy. As the demand for autologous treatments grows, particularly in oncology and orthopedics, the need for advanced, minimally invasive, and automated harvesting systems has intensified. Adoption of closed-system and scalable cell harvesters is increasing, as these technologies offer enhanced sterility, reproducibility, and compliance with regulatory standards, aligning with the growing emphasis on individualized medicine.

Key Market Players

• Human Med AG
• ADS Biotec Inc.
• PerkinElmer Inc.
• Cytiva
• TERUMO BCT, INC.
• Esco Micro Pte. Ltd.
• Gasser Apparatebau und Laborzubehor
• Sartorius AG
• Cox Scientific Ltd.
• Pall Corporation

Report Scope

In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Harvester Market, By Type:

• Displacement Collector
• Therapy Collector

Cell Harvester Market, By Application:

• Cell Proliferation Assays
• Mixed Lymphocyte Culture (MLC) Assays
• Receptor-Binding Assays
• Single-Stranded Template DNA Harvesting
• Others

Cell Harvester Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Harvester Market.

Available Customizations:

Global Cell Harvester Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Harvester Market

5. Global Cell Harvester Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Displacement Collector, Therapy Collector)
  • 5.2.2. By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Cell Harvester Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Harvester Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Cell Harvester Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Cell Harvester Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Cell Harvester Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Harvester Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Cell Harvester Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Cell Harvester Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Cell Harvester Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Cell Harvester Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Cell Harvester Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell Harvester Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Cell Harvester Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Cell Harvester Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Cell Harvester Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Cell Harvester Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Cell Harvester Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Harvester Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Cell Harvester Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Cell Harvester Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Harvester Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Harvester Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Cell Harvester Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Cell Harvester Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Harvester Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Human Med AG
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. ADS Biotec Inc.
• 16.3. PerkinElmer Inc.
• 16.4. Cytiva
• 16.5. TERUMO BCT, INC.
• 16.6. Esco Micro Pte. Ltd.
• 16.7. Gasser Apparatebau und Laborzubehor
• 16.8. Sartorius AG
• 16.9. Cox Scientific Ltd.
• 16.10. Pall Corporation

17. Strategic Recommendations

18. About Us & Disclaimer